Equity How Chipiron's rethinking the future of MRI
43 snips
Sep 24, 2025 Evan Kervella, founder and CEO of Chipiron, aims to revolutionize MRI accessibility with low-field MRI machines that break away from costly traditional setups. He discusses the challenges of making MRI technology affordable and portable, allowing for wider use outside hospitals. Evan shares insights on improving patient experience with quieter, family-friendly designs and simplifying installation. He also touches on the excitement around AI in diagnostics, the shifting investment landscape, and potential exit strategies for medical tech startups.
AI Snips
Chapters
Transcript
Episode notes
Root Cause Of MRI Inaccessibility
- MRI's core accessibility problem is the reliance on high-field superconducting magnets cooled by liquid helium.
- Chipiron targets low-field MRI to remove that single root cause and unlock much broader deployment.
Prototypes Lead To Clinical Deployment
- Chipiron has built multiple prototype iterations and is preparing a third capable of full-body in vivo imaging.
- They plan internal in vivo images between year-end and next summer and a hospital prototype for trials by end of 2026.
Cost Of Ownership Beats Sticker Price
- Chipiron estimates total cost of ownership will be under 25% of current MRI machines by removing heavy infrastructure needs.
- The biggest customer value is massively simpler installation and operation, not only lower price.